South Valley University, Qena Faculty of Medicine, Obstetrics and Gynecology Department
Qina, Qena Governorate, Egypt
NCT Number: NCT04178473
Uterovaginal prolapse is a common disease. Due to high failure rate that occur following vaginal hysterectomy, sacrocolpopexy is investigated by many resarchers to manage uterovaginal prolapse in non-hystrectomized women.
In this study the investigator will compare the result of total versus subtotal hysterectomy at the time of sacrocolpopexy.
Study design: Randomized controlled trial
Intervention:
Group A will have total abdominal hysterectomy Group B will have subtotal abdominal hysterectomy
Looking for future studies?
Notify Me40 year and older
Female
Interventional
Not applicable
Qina, Qena Governorate, Egypt
Uterovaginal prolapse is a common disease. Sacrocolpopexy is essentially invented to manage prolapse of the vault following hysterectomy. Due to high failure rate that occur following vaginal hysterectomy, sacrocolpopexy is investigated by many resarchers to manage uterovaginal prolapse in non-hystrectomized women. The main drawback of sacrocolpopexy is the risk of mesh erosion. The incidence of mesh erosion is 0-5% at follow up of 1 year and 0.5% at follow up of 7 years. After total hysterectomy, the mesh is sutured to the vaginal wall using non-absorbable sutures. Sutures that span the whole thickness of vaginal and involve the vaginal skin was considered the probable factor that result in mesh erosion. After subtotal hysterectomy, the mesh is fixed to the anterior and the posterior cervical surfaces. The cervix has thick wall and the risk associated with "deep" stiches does not exist.
In this study the investigator will compare the result of total versus subtotal hysterectomy at the time of sacrocolpopexy.
Patients and methods
Study design:
Randomized controlled trial
Patients:
Data will be collected from the patients admitted to the obstetrics and gynecology department, Qen faculty of medicine, South Valley University, Egypt from the 1st of January 2019 until 30th of December 2019. Follow up data will be collected until 30th of December 2020. Written consent will be obtained at time of recruitment. The Inclusion criteria are nonhystrectomized patients who will undergo sacrocolpopexy. Exclusion criteria were (1) women age less than 40; (2) desire to retain the uterus; (3) women who are unfit for lengthy surgery. Randomization will be through closed envelop method.
Intervention Group A will have total abdominal hysterectomy Group B will have subtotal abdominal hysterectomy Sacrocolpopexy will be done using Polypropylene mesh. Both groups will be done by the same surgeon using the following technique: dissection of the vesicovaginal and the rectovaginal spaces to prepare for the site of mesh placement. Dissection will be continued in the rectovaginal septum using sharp and blunt dissection until reaching the level of the levator ani (the length of the posterior vaginal mesh arm is nearly equal to the total vaginal length). The limit of the dissection in the vesicovaginal plane is down to the bladder neck (known by palpation of the Foley's catheter balloon) after lateralization of the ureters. The mesh is sutured to the anterior and the posterior vaginal wall the mesh using non-absorbable sutures. In women with subtotal hysterectomy, the mesh will be also sutured to the cervix. The mesh is then sutured to the anterior longitudinal ligament on the anterior surface of the fifth lumbar vertebra and the sacral promontory using non-absorbable sutures. Suturing of the peritoneum over the mesh will be done.
Outcomes:
The primary outcome will be mesh erosion. Secondary outcomes will be complications including recurrence
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
total abdominal hysterectomy at time of sacrocolpopexy
Subtotal abdominal hysterectomy at time of sacrocolpopexy
Time frame: 12 months or more
Mesh exposure through the lumen of the vagina, bladder, or rectum
Time frame: 12 months or more
recurrence of vaginal wall prolapse or vault prolapse
South Valley University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07194343
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
Barcelona, Spain
View Trial DetailsNCT03947164
Prolapse Genital
Rennes, Brittany Region, France
View Trial DetailsNCT05463081
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Tver', Tver Oblast, Russia
View Trial DetailsNCT05571072
Neurologic Manifestations, Opioid Use
Cleveland, Ohio, United States
View Trial Details